Our INFANT study screens for about 200 treatable childhood conditions.
These conditions were chosen because early detection—and early treatment—has been shown to improve health outcomes.
Genomic newborn screening does not test for every genetic condition or health issue. It is still possible for a baby with a screen-negative result to develop a condition not included in this study.
A condition is included in this study if:
To see the complete list of genes/conditions screened for by INFANT, please visit: NSO's INFANT study page.
There is no cost to join the study.
Participation is voluntary and will not affect your baby’s standard newborn screening or their usual medical care.
If you choose to register your interest, you’ll complete consent and your baby will go through eligibility screening.
Your baby may be able to join if they:
There are a few additional screening steps. Some babies may not be eligible if:
If testing can’t happen, we will inform you.
It’s important to be aware of:
If you’re unsure, the study team or your healthcare provider can help you think through your decision.
Your baby’s sample and data are protected by strict privacy rules:
If you ever have privacy questions, contact infant@cheo.on.ca.
The INFANT study is a research study exploring whether genomic newborn screening should be added to Ontario’s standard newborn screening. It is led by Newborn Screening Ontario (NSO) and approved by the CHEO Research Ethics Board. NSO oversees Ontario’s newborn screening program and works with hospitals and healthcare providers to help find serious but treatable conditions early.
Families may be contacted to:
You can withdraw your baby from the study at any time. This will not affect their standard newborn screening or their usual medical care.
You can speak with your healthcare provider or contact the study team anytime.
Email: infant@cheo.on.ca
A small step now could mean big leaps later.
